Brian Daniel Webster, Director at Kestra Medical Technologies, sold KMTS on Aug 3, 2026
Data as of Oct 16
▼ SELL$311K13,017 shares at $23.92Brian Daniel Webster DirectorKMTS Kestra Medical Technologies, Ltd.
- Traded
- Aug 3, 2026
- Disclosed
- Aug 3, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
KMTS since disclosure
+13.5%
after the sale
Similar stocks (XLV) since disclosure
+8.9%
XLV — its sector index fund
Change in closing price from Aug 3, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLBrian Daniel Webster DirectorKMTS Kestra Medical Technologies, Ltd.$202Kdisclosed Aug 3 · filed 3 days after the trade
- ▼ SELLBrian Daniel Webster DirectorKMTS Kestra Medical Technologies, Ltd.$179Kdisclosed Aug 3 · filed 4 days after the trade